Jaewon Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jaewon Lee has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Kwang-Woong Lee
Department of Surgery, Seoul National University Hospital, Seoul, Korea
23 shared publications - YoungRok Choi
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
23 shared publications - Su Young Hong
Department of Surgery, Seoul National University Hospital, Seoul, Korea
22 shared publications - Jiyoung Kim
Department of Surgery Seoul National University College of Medicine Seoul South Korea
21 shared publications - Jae-Yoon Kim
Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
19 shared publications - Kyung-Suk Suh
Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea
19 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Impact of allocation priority for children awaiting liver transplantation in Korea: a pediatric liver allocation simulated model analysis
Jaewon Lee, YoungRok Choi, Nam-Joon Yi, Kyung Chul Yoon, Jiyoung Kim, Jae-Yoon Kim, Hyun Hwa Choi, Sola Lee, Su young Hong, Suk Kyun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0062
- 9 April 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
Open AccessImpact of allocation priority for children awaiting liver transplantation in Korea: a pediatric liver allocation simulated model analysis
Jaewon Lee, YoungRok Choi, Nam-Joon Yi, Kyung Chul Yoon, Jiyoung Kim, Jae-Yoon Kim, Hyun Hwa Choi, Sola Lee, Su young Hong, Suk Kyun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0062
- Open Access
- 12 February 2026
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 6 (1) , 33-40
Rapamycin mitigates warm ischemia-induced peribiliary fibrosis: A non-transplant experimental model with implications for ischemic cholangiopathy
Hyun Hwa Choi, Geun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jiyoung Kim, Jaewon Lee, Su Young Hong, Suk Kyun Hong, YoungRok Choi. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0022
- 12 February 2026
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 6 (1) , 33-40
Open AccessRapamycin mitigates warm ischemia-induced peribiliary fibrosis: A non-transplant experimental model with implications for ischemic cholangiopathy
Hyun Hwa Choi, Geun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jiyoung Kim, Jaewon Lee, Su Young Hong, Suk Kyun Hong, YoungRok Choi. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0022
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (6) , 366-373
Anatomical risk stratification for major portal vein complications in dual portal vein living donor liver transplantation: a retrospective cohort study
Choi HH, et al. Ann Surg Treat Res. 2026 Jun;110(6):366-373. https://doi.org/10.4174/astr.2026.110.6.366
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (6) , 366-373
Open AccessAnatomical risk stratification for major portal vein complications in dual portal vein living donor liver transplantation: a retrospective cohort study
Choi HH, et al. Ann Surg Treat Res. 2026 Jun;110(6):366-373. https://doi.org/10.4174/astr.2026.110.6.366
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (4) , 273-280
Effect of weight reduction on liver volume in living liver donors with steatosis: a retrospective cohort study
Hong K, et al. Ann Surg Treat Res. 2026 Apr;110(4):273-280. https://doi.org/10.4174/astr.2026.110.4.273
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (4) , 273-280
Open AccessEffect of weight reduction on liver volume in living liver donors with steatosis: a retrospective cohort study
Hong K, et al. Ann Surg Treat Res. 2026 Apr;110(4):273-280. https://doi.org/10.4174/astr.2026.110.4.273
- Open Access
- 30 October 2025
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 5 (2) , 89-97
Evaluating a 3D-printed biodegradable paclitaxel-eluting stent for biliary stricture management after liver transplantation: An in vivo porcine study
Jiyoung Kim, YoungRok Choi, Joon Koo Han, Jae Hyun Kim, Dong-Heon Ha, Eui Soo Han, Jiwon Koh, Jae-Yoon Kim, Jaewon Lee, Hyun Hwa Choi, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0013
- 30 October 2025
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 5 (2) , 89-97
Open AccessEvaluating a 3D-printed biodegradable paclitaxel-eluting stent for biliary stricture management after liver transplantation: An in vivo porcine study
Jiyoung Kim, YoungRok Choi, Joon Koo Han, Jae Hyun Kim, Dong-Heon Ha, Eui Soo Han, Jiwon Koh, Jae-Yoon Kim, Jaewon Lee, Hyun Hwa Choi, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0013
- 12 September 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (9) , e70314
Integrating Alpha‐Fetoprotein and Protein Induced by Vitamin K Antagonist‐II as Surveillance Tools After Liver Transplantation for Hepatocellular Carcinoma: A Novel Protocol for Early Detection of Tumor Recurrence
Hepatocellular carcinoma (HCC) is a cancer prevalent worldwide, and liver transplantation (LT) is a curative treatment option. However, post‐transplantation recurrence remains a significant concern, necessitating the identification of predictive factors and early detection of patients with recurrence. Alpha‐fetoprotein (AFP) and proteins induced by vitamin K absence‐II (PIVKA‐II) are recognized HCC diagnostic markers. However, standardized protocols for testing intervals and supplemental imaging incorporation are limited. This study explored the integration of both tumor markers as surveillance tools and suggested different surveillance protocols based on recurrence risk. We conducted a retrospective analysis of 708 patients who underwent living donor liver transplantation (LDLT) for HCC. Patients were categorized into four groups based on models for tumor recurrence after liver transplantation (MoRAL) scores and tumor marker normalization after LT. Group 1, with the lowest risk, showed 12.5% recurrence at 15 months, whereas Group 4 showed 96.2% recurrence within 5 months. Integrating AFP and PIVKA‐II yielded an overall 82% sensitivity for recurrence detection. As 28.0% of patients with HCC recurrence in Group 1 revealed recurrence without tumor marker elevation, we propose a novel HCC surveillance protocol with differentiated intervals based on specific risk groups. This approach is promising for enhancing early detection and post‐transplantation outcomes.
- 12 September 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (9) , e70314
Integrating Alpha‐Fetoprotein and Protein Induced by Vitamin K Antagonist‐II as Surveillance Tools After Liver Transplantation for Hepatocellular Carcinoma: A Novel Protocol for Early Detection of Tumor Recurrence
Hepatocellular carcinoma (HCC) is a cancer prevalent worldwide, and liver transplantation (LT) is a curative treatment option. However, post‐transplantation recurrence remains a significant concern, necessitating the identification of predictive factors and early detection of patients with recurrence. Alpha‐fetoprotein (AFP) and proteins induced by vitamin K absence‐II (PIVKA‐II) are recognized HCC diagnostic markers. However, standardized protocols for testing intervals and supplemental imaging incorporation are limited. This study explored the integration of both tumor markers as surveillance tools and suggested different surveillance protocols based on recurrence risk. We conducted a retrospective analysis of 708 patients who underwent living donor liver transplantation (LDLT) for HCC. Patients were categorized into four groups based on models for tumor recurrence after liver transplantation (MoRAL) scores and tumor marker normalization after LT. Group 1, with the lowest risk, showed 12.5% recurrence at 15 months, whereas Group 4 showed 96.2% recurrence within 5 months. Integrating AFP and PIVKA‐II yielded an overall 82% sensitivity for recurrence detection. As 28.0% of patients with HCC recurrence in Group 1 revealed recurrence without tumor marker elevation, we propose a novel HCC surveillance protocol with differentiated intervals based on specific risk groups. This approach is promising for enhancing early detection and post‐transplantation outcomes.
- 24 July 2025
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (2) , 270-272
Comparative analyses of anastomosis methods for dual portal vein right lobe grafts in living donor liver transplantation: A retrospective study
- 24 July 2025
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (2) , 270-272
Comparative analyses of anastomosis methods for dual portal vein right lobe grafts in living donor liver transplantation: A retrospective study
- Open Access
- 20 June 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (9) , 6114-6122
Indocyanine green fluorescence predicts biliary complications in living donor liver transplantation: a prospective cohort study
Background: Biliary complications (BCs) following living donor liver transplantation (LDLT) are common. To minimize BCs and improve surgical outcomes, indocyanine green (ICG) fluorescence intensity (FI) is used to assess bile duct perfusion. This study investigated the association between ICG FI in the common bile duct (CBD) and postoperative BCs in patients undergoing LDLT. Materials and methods: In this prospective cohort study, FI parameters (maximum intensity, half-maximal intensity, time to maximum, time to half-maximal intensity, and slope) were analyzed using ImageJ. Fifty-four patients aged ≥19 years who underwent LDLT at our single tertiary hospital between July 2022 and December 2023 were included, with a 1-year follow-up period for BCs. The exclusion criteria were re-transplantation, multi-organ transplants, or hepaticojejunostomy. Following hepatic vein, portal vein, and hepatic artery anastomoses, ICG (0.05 mg/kg) was administered intravenously before biliary reconstruction. CBD FI was measured at 10-s intervals for 3 minutes. The primary outcome was BC occurrence P = 0.008, P = 0.031, and P = 0.009, respectively). Logistic regression further identified low slope and delayed cold ischemic time as independent risk factors (hazard ratio and 95% confidence interval: 0.09, 0.01–0.82, P = 0.032; and 6.07, 1.29–28.59, P = 0.023, respectively). Conclusion: ICG FI slope ≤0.8 and cold ischemic time >135.5 minutes were identified as potential risk factors for BCs following LDLT. Assessing recipient CBD perfusion to predict postoperative BCs represents a novel approach in LDLT research.
- 20 June 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (9) , 6114-6122
Open AccessIndocyanine green fluorescence predicts biliary complications in living donor liver transplantation: a prospective cohort study
Background: Biliary complications (BCs) following living donor liver transplantation (LDLT) are common. To minimize BCs and improve surgical outcomes, indocyanine green (ICG) fluorescence intensity (FI) is used to assess bile duct perfusion. This study investigated the association between ICG FI in the common bile duct (CBD) and postoperative BCs in patients undergoing LDLT. Materials and methods: In this prospective cohort study, FI parameters (maximum intensity, half-maximal intensity, time to maximum, time to half-maximal intensity, and slope) were analyzed using ImageJ. Fifty-four patients aged ≥19 years who underwent LDLT at our single tertiary hospital between July 2022 and December 2023 were included, with a 1-year follow-up period for BCs. The exclusion criteria were re-transplantation, multi-organ transplants, or hepaticojejunostomy. Following hepatic vein, portal vein, and hepatic artery anastomoses, ICG (0.05 mg/kg) was administered intravenously before biliary reconstruction. CBD FI was measured at 10-s intervals for 3 minutes. The primary outcome was BC occurrence P = 0.008, P = 0.031, and P = 0.009, respectively). Logistic regression further identified low slope and delayed cold ischemic time as independent risk factors (hazard ratio and 95% confidence interval: 0.09, 0.01–0.82, P = 0.032; and 6.07, 1.29–28.59, P = 0.023, respectively). Conclusion: ICG FI slope ≤0.8 and cold ischemic time >135.5 minutes were identified as potential risk factors for BCs following LDLT. Assessing recipient CBD perfusion to predict postoperative BCs represents a novel approach in LDLT research.
- Open Access
- 15 January 2025
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 29 (1) , 32-37
Feasibility of indocyanine green fluorescence imaging to predict biliary complications in living donor liver transplantation: A pilot study
Jaewon Lee, YoungRok Choi, Nam-Joon Yi, Jae-Yoon Kim, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.24-196
- 15 January 2025
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 29 (1) , 32-37
Open AccessFeasibility of indocyanine green fluorescence imaging to predict biliary complications in living donor liver transplantation: A pilot study
Jaewon Lee, YoungRok Choi, Nam-Joon Yi, Jae-Yoon Kim, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee, Kyung-Suk Suh. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.24-196
- Open Access
- 1 December 2024
- Published by Korean Society for Parenteral and Enteral Nutrition/The Korean Society of Surgical Metabolism and Nutrition in Annals of Clinical Nutrition and Metabolism
- Vol. 16 (3) , 125-133
Incidence and risk factors of nonalcoholic fatty liver disease after pancreaticoduodenectomy in Korea: a multicenter retrospective cohort study
Chang-Sup Lim, Hongbeom Kim, In Woong Han, Won-Gun Yun, Eunchae Go, Jaewon Lee, Kyung Chul Yoon, So Jeong Yoon, Sang Hyun Shin, Jin Seok Heo, Yong Chan Shin, Woohyun Jung. Ann Clin Nutr Metab 2024;16:125-33. https://doi.org/10.15747/ACNM.2024.16.3.125
- 1 December 2024
- Published by Korean Society for Parenteral and Enteral Nutrition/The Korean Society of Surgical Metabolism and Nutrition in Annals of Clinical Nutrition and Metabolism
- Vol. 16 (3) , 125-133
Open AccessIncidence and risk factors of nonalcoholic fatty liver disease after pancreaticoduodenectomy in Korea: a multicenter retrospective cohort study
Chang-Sup Lim, Hongbeom Kim, In Woong Han, Won-Gun Yun, Eunchae Go, Jaewon Lee, Kyung Chul Yoon, So Jeong Yoon, Sang Hyun Shin, Jin Seok Heo, Yong Chan Shin, Woohyun Jung. Ann Clin Nutr Metab 2024;16:125-33. https://doi.org/10.15747/ACNM.2024.16.3.125